Abstract
There is a need for the study of complex diseases due to their important impact on our society. One of the solutions involves the theoretical methods which are fast and efficient tools that can lead to the discovery of new active drugs specially designed for these diseases. The Quantitative Structure - Activity Relationship models (QSAR) and the complex network theory become important solutions for screening and designing efficient pharmaceuticals by coding the chemical information of the molecules into molecular descriptors. This review presents the most recent studies on drug discovery and design using QSAR of several complex diseases in the fields of Neurology, Cardiology and Oncology.
Keywords: Drug design, QSAR, graphs, complex network, complex disease, QSAR Computational Methods, Drug Discovery, biochemical networks, drug-target interactions, protein-protein interaction networks, protein folding kinetics, (QPDRs), physio-chemical properties, Neurology, Cardiology, Oncology, QSAR models, TIs/CIs, information indices, MARCHINSIDE
Current Pharmaceutical Design
Title: Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Volume: 16 Issue: 24
Author(s): Cristian R. Munteanu, Enrique Fernandez-Blanco, Jose A. Seoane, Pilar Izquierdo-Novo, Jose Angel Rodriguez-Fernandez, Jose Maria Prieto-Gonzalez, Juan R. Rabunal and Alejandro Pazos
Affiliation:
Keywords: Drug design, QSAR, graphs, complex network, complex disease, QSAR Computational Methods, Drug Discovery, biochemical networks, drug-target interactions, protein-protein interaction networks, protein folding kinetics, (QPDRs), physio-chemical properties, Neurology, Cardiology, Oncology, QSAR models, TIs/CIs, information indices, MARCHINSIDE
Abstract: There is a need for the study of complex diseases due to their important impact on our society. One of the solutions involves the theoretical methods which are fast and efficient tools that can lead to the discovery of new active drugs specially designed for these diseases. The Quantitative Structure - Activity Relationship models (QSAR) and the complex network theory become important solutions for screening and designing efficient pharmaceuticals by coding the chemical information of the molecules into molecular descriptors. This review presents the most recent studies on drug discovery and design using QSAR of several complex diseases in the fields of Neurology, Cardiology and Oncology.
Export Options
About this article
Cite this article as:
R. Munteanu Cristian, Fernandez-Blanco Enrique, A. Seoane Jose, Izquierdo-Novo Pilar, Angel Rodriguez-Fernandez Jose, Maria Prieto-Gonzalez Jose, R. Rabunal Juan and Pazos Alejandro, Drug Discovery and Design for Complex Diseases through QSAR Computational Methods, Current Pharmaceutical Design 2010; 16 (24) . https://dx.doi.org/10.2174/138161210792389252
DOI https://dx.doi.org/10.2174/138161210792389252 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.
This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more
Blood-based biomarkers in large-scale screening for neurodegenerative diseases
Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine
Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pathobiology of Stent Thrombosis after Drug-Eluting Stent Implantation
Current Pharmaceutical Design Clinical Use of Aspirin in Ischemic Heart Disease: Past, Present and Future
Current Pharmaceutical Design Respiratory Stem Cells and Progenitors: Overview, Derivation, Differentiation, Carcinogenesis, Regeneration and Therapeutic Application
Current Stem Cell Research & Therapy Cytochrome P450s: Mechanisms and Biological Implications in Drug Metabolism and its Interaction with Oxidative Stress
Current Drug Metabolism New Immunosuppressants: Immunosuppression and Immunomodulation
Medicinal Chemistry Reviews - Online (Discontinued) Oxidative Stress in Essential Hypertension
Current Pharmaceutical Design Current HIV Treatment Guidelines - An Overview
Current Pharmaceutical Design Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases
Current Pharmaceutical Design MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders
Current Genomics Trick-or-Treat: Dietary Lipids and Host Resistance to Infectious Disease
Mini-Reviews in Medicinal Chemistry Sleep Apnea: an Underestimated Cause of Resistant Hypertension
Current Hypertension Reviews Contemporary Animal Models For Human Gene Therapy Applications
Current Gene Therapy Dietary Intake and Physical Activity in a Canadian Population Sample of Male Patients with HIV Infection and Metabolic Abnormalities
Current HIV Research The Applications of Biomarkers in Early Clinical Drug Development to Improve Decision-Making Processes
Current Clinical Pharmacology Childhood and Adulthood Rural Residence Increases the Risk of Dementia: NEDICES Study
Current Alzheimer Research Acute Antithrombotic Treatment of Ischemic Stroke
Current Vascular Pharmacology MicroRNA-21: From Cancer to Cardiovascular Disease
Current Drug Targets Dietary Intervention for Allergic Disease
Current Pharmaceutical Design The Sleeping Beauty Transposon Vector System for Treatment of Rare Genetic Diseases: An Unrealized Hope?
Current Gene Therapy The Involvement of PPARs in the Causes, Consequences and Mechanisms for Correction of Cardiac Lipotoxicity and Oxidative Stress
Current Molecular Pharmacology